Highly concentrated scalp care in ampoules for markedly thinning hair. It strengthens the hair roots and supports visibly fuller hair.
Clinically tested: Together with 1.3 and 3.1: share of hairs in the growth phase up from 76.7 % to 81.2 % in 12 weeks; 92 % noticed less hair loss (25 participants). See the study ↓
Key benefits
- Reduces hair loss – shown in a study
- Strengthens the hair roots
- For visibly fuller hair
- Complements lotion 3.4.3A
Key ingredients
- CEGABA – active complex with GABA, cares for scalp and hair roots
- Saw palmetto extract and apple stem cell culture – protect the hair roots; saw palmetto inhibits 5-α-reductase in laboratory studies · More & studies
- Açaí extract – rich in antioxidants, protects the scalp from oxidative stress
- Nicotinamide (vitamin B3) – cares for the scalp and strengthens its barrier
- Soy proteins – supply the hair roots with proteins
More about the actives and the studies behind them: Saw palmetto, caffeine, Capixyl™ & co.
Please note
Test on a small area of skin before first use. Do not use during pregnancy or breastfeeding.
Cosmetic product. Stop using in case of irritation.
Full ingredient list (INCI)
Aqua (Water), Alcohol Denat., Hydrolyzed Soy Protein, Carboxyethyl Aminobutyric Acid, Euterpe Oleracea Fruit Extract, Serenoa Serrulata Fruit Extract, Malus Domestica Fruit Cell Culture Extract, Glycerin, Niacinamide, Xanthan Gum, Propanediol, Potassium Sorbate, Sorbic Acid, Sodium Benzoate, Benzoic Acid, Phenoxyethanol
Apply 1/3 of the ampoule to dry or damp scalp, preferably in the evening. Massage in, do not rinse. Daily, for at least 3 months.
These products are used together with this product in care routines and studies.
Care routines
Efficacy study: 1.3 Peeling + 3.1 Intense Shampoo + 3.4.3B Fresh Cells Concentrate
The combination of 1.3 Dixidox de Luxe Peeling, 3.1 Dixidox de Luxe Intense Shampoo and 3.4.3B Fresh Cells de Luxe Concentrate was used for 12 weeks under dermatological supervision by 25 people (aged 23–68) with hereditary hair loss (androgenetic alopecia). In the trichological examination of 15 participants with increased hair loss, the share of hairs in the resting phase (telogen) fell on average from 20.3 % to 16.8 %, and the share of hairs in the growth phase (anagen) rose from 76.7 % to 81.2 %. In 7 of 10 participants, Visioscan® images showed new hair growth. 92 % of participants reported less hair loss.
Measured and rated by participants
- −17 % Share of hairs in the resting phase (telogen), avg. 20.3 % → 16.8 %
-
81.2 % Hairs in the growth phase (anagen), before avg. 76.7 %
-
7 of 10 New hair growth in Visioscan® images
- 100 % Hair looks healthier
-
96 % Hair growth promoted
-
96 % Better than previously used products
-
92 % Less hair loss
-
83 % More hair density
- Participants
- 25 people, aged 23–68 (avg. 46), with androgenetic alopecia; trichological examination in 15, Visioscan® images in 10 people
- Duration
- 12 weeks
- Test lab
- J.S. Hamilton Poland S.A.
Full study ↓
